Mehdi Nejati-Moheimani

Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice

S. Bouzari, S. Siadat, Maryam Golshani, 2018, Molecular immunology.

Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c Mice.

S. Rafati, S. Bouzari, Maryam Golshani, 2017, International journal of medical microbiology : IJMM.

In silico design, cloning and high level expression of L7/L12-TOmp31 fusion protein of Brucella antigens

A. Jahanian-Najafabadi, S. Rafati, F. Shahcheraghi, 2015, Research in pharmaceutical sciences.

Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.

S. Rafati, F. Shahcheraghi, S. Bouzari, 2015, Molecular immunology.

Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice.

S. Bouzari, Seyed Davar Siadat, Maryam Golshani, 2020, International immunopharmacology.

Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice.

S. Rafati, S. Bouzari, Maryam Golshani, 2016, Veterinary microbiology.